EN HU

Erdei Annamária

Publication list

Uploaded publications:
51
Publications in DEA:
51
OA:
20
Date range:
2004-2024
2024
1.
Papp, F. R., Katkó, M., Csiki, R., Galgóczi, E., Molnár, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 65 (13), 1-12, (article identifier: 13), 2024.
Journal metrics:
Q2 Cellular and Molecular Neuroscience (2023)
D1 Ophthalmology (2023)
Q1 Sensory Systems (2023)
2023
2.
Ratku, B., Borbásné Sebestyén, V., Szelesné Árokszállási, A., Erdei, A., Berta, E., Szabó, Z., Bodor, M., Nagy, E. V., Somodi, S.: A felnőttkori növekedésihormon-hiány szív- és érrendszeri szövődményei.
Orv. hetil. 164 (41), 1616-1627, 2023.
Journal metrics:
Q4 Medicine (miscellaneous)
3.
Erdei, A., Ménes, E., Emri, G.: Endocrine side effects of immune-checkpoint inhibitors in patients with malignant melanoma.
Endocrine Abstracts. 90, EP678, 2023.
4.
Dániel, E., Nagy, B. E., Nagy, E. V., Erdei, A.: Kezelés nélkül javuló acromegalia a pandémia alatt.
Metabolizmus. 21 (2), 86-89, 2023.
2022
5.
Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H. P., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E. V.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.
Journal metrics:
Q4 Endocrine and Autonomic Systems
Q4 Endocrinology
Q4 Endocrinology, Diabetes and Metabolism
Q4 Medicine (miscellaneous)
Q4 Neurology
Q4 Neurology (clinical)
Q4 Psychiatry and Mental Health
6.
Erdei, A., Dániel, E., Gazdag, A., Griger, M., Nagy, E. B., Nagy, E. V.: Cessation of GH secretion in acromegaly without medical or surgical intervetion: Covid-postponed surgery was escaped.
Endocrine Abst. 81, EP704, 2022.
7.
Aranyosi, J. K., Galgóczi, E., Erdei, A., Katkó, M., Fodor, M., Ujhelyi, Z., Bácskay, I., Nagy, E. V., Ujhelyi, B.: Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.
Molecules. 27 (9), 1-14, 2022.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
8.
Ratku, B., Borbásné Sebestyén, V., Erdei, A., Nagy, E. V., Szabó, Z., Somodi, S.: Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.
Pituitary. 25 (2), 211-228, 2022.
Journal metrics:
Q2 Endocrinology
Q2 Endocrinology, Diabetes and Metabolism
9.
Erdei, A.: G4-immunglobulinnal társult endokrin betegségek.
Orv. hetil. 163 (30), 1175-1180, 2022.
Journal metrics:
Q4 Medicine (miscellaneous)
10.
Galgóczi, E., Katkó, M., Papp, F. R., Csiki, R., Csiha, S., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts: a Potential Pleiotropic Effect in Graves' Orbitopathy.
Molecules. 28 (1), 1-12, 2022.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
11.
Erdei, A., Gazdag, A., Ujhelyi, B., Nagy, E. B., Berényi, E., Berta, E., Steiber, Z., Barna, S., Mezősi, E., Bodor, M., Nagy, E. V.: Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.
Eur. Thyroid J. 11 (5), 1-10, 2022.
Journal metrics:
Q2 Endocrinology, Diabetes and Metabolism
12.
Galgóczi, E., Katkó, M., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: The effect of glucocorticoids on hyaluronan production of orbital fibroblasts.
Endocrine Abst. 84, PS2-07-64, 2022.
13.
Katkó, M., Gazdag, A., Harangi, M., Szentpéteri, A., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Bhattoa, H. P., Nagy, E. V.: The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355, e163, 2022.
2021
14.
Erdei, A.: Endokrin orbitopathia.
Orvostovábbk. szle. 28 (1), 1-7, 2021.
15.
Katkó, M., Galgóczi, E., Erdei, A., Gazdag, A., Berta, E., Bodor, M., Seres, I., Hircsu, I., Badics, Á., Ujhelyi, B., Sira, L., Bhattoa, H. P., Nagy, E. V.: The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
J. Inflamm. Res. 14, 1883-1890, 2021.
Journal metrics:
Q2 Immunology
Q2 Immunology and Allergy
2020
16.
Hircsu, I., Gazdag, A., Bodor, M., Berta, E., Andrási, M., Kanyári, Z., Győry, F., Barna, S., Bhattoa, H. P., Nagy, B. J., Nagy, E. V., Erdei, A.: A multiplex endokrin neoplasia-2A szindrómáról egy család kapcsán.
Orv. hetil. 161 (2), 75-79, 2020.
Journal metrics:
Q4 Medicine (miscellaneous)
17.
Steiber, Z., Erdei, A., Nagy, E. V., Ujhelyi, B.: Az endokrin orbitopathia korszerű kezelése.
Szemészet. 157 (2), 19-23, 2020.
18.
Galgóczi, E., Jeney, F., Katkó, M., Erdei, A., Gazdag, A., Sira, L., Bodor, M., Berta, E., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 61 (2), 1-8, 2020.
Journal metrics:
Q1 Cellular and Molecular Neuroscience
D1 Ophthalmology
Q1 Sensory Systems
19.
Aranyosi, J. K., Deli, T., Erdei, A., Tóth, G., Jakab, A., Fodor, M., Nagy, E. V., Ujhelyi, B.: Unusual onset of thyroid associated orbitopathy during pregnancy: case report and review of literature.
BMC Endocr. Disord. 20 (1), 1-5, 2020.
Journal metrics:
Q2 Endocrinology, Diabetes and Metabolism
Q2 Medicine (miscellaneous)
2019
20.
Győry, F., Fedor, R., Andrási, M., Barna, S., Bedekovics, J., Erdei, A., Damjanovich, L., Kovács, D. Á.: A Basedow-kór és differenciált pajzsmirigy-carcinoma onkológiai-sebészeti vonatkozásai tapasztalataink alapján.
Magyar Seb. 72 (3), 118-119, 2019.
21.
Berta, E., Lengyel, I., Halmi, S., Zrínyi, M., Erdei, A., Harangi, M., Páll, D., Nagy, E. V., Bodor, M.: Hypertension in thyroid disorders.
Front Endocrinol (Lausanne). 10, 1-11, 2019.
Journal metrics:
Q1 Endocrinology, Diabetes and Metabolism
22.
Kövesdi, A., Tóth, M., Butz, H., Szűcs, N., Sármán, B., Pusztai, P., Tőke, J., Reismann, P., Fáklya, M., Tóth, G., Somogyi, A., Borka, K., Erdei, A., Nagy, E. V., Deák, V., Valkusz, Z., Igaz, P., Patócs, A., Grolmusz, V. K.: True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.
Endocrine. 65 (2), 451-459, 2019.
Journal metrics:
Q2 Endocrinology
Q2 Endocrinology, Diabetes and Metabolism
2018
23.
Berta, E., Bodor, M., Galuska, L., Paragh, G., Erdei, A., Gazdag, A., Ujhelyi, B., Berényi, E., Katkó, M., Gazsó, A., Nagy, E. V.: Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up.
Exp. Clin. Endocrinol. Diabet. 126 (10), 628-631, 2018.
Journal metrics:
Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Q2 Internal Medicine
Q2 Medicine (miscellaneous)
24.
Erdei, A., Steiber, Z., Molnár, C., Berényi, E., Nagy, E. V.: Exophthalmos in a young woman with no Graves' disease: a case report of IgG4-related orbitopathy.
BMC Ophthalmol. 18 (1), 1-6, 2018.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Ophthalmology
25.
Kövesdi, A., Balogh, K., Tóth, M., Szűcs, N., Sármán, B., Pusztai, P., Reismann, P., Somogyi, A., Borka, K., Erdei, A., Deák, V., Valkusz, Z., Igaz, P., Patócs, A., Grolmusz, V. K., Erdei, A.: Gastroenteropancreatic neuroendocrine tumors are predictive for a positive MEN1 germline mutation test: evidence from Hungarian MEN1 cohort.
Endocrine Abst. 56, P126, 2018.
DEENK University of Debrecen
© 2012 University of Debrecen